IE44540L - Controlled release tablet - Google Patents

Controlled release tablet

Info

Publication number
IE44540L
IE44540L IE762231A IE223176A IE44540L IE 44540 L IE44540 L IE 44540L IE 762231 A IE762231 A IE 762231A IE 223176 A IE223176 A IE 223176A IE 44540 L IE44540 L IE 44540L
Authority
IE
Ireland
Prior art keywords
controlled release
release tablet
medicament
hydrophilic
core
Prior art date
Application number
IE762231A
Other versions
IE44540B1 (en
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IE44540L publication Critical patent/IE44540L/en
Publication of IE44540B1 publication Critical patent/IE44540B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)

Abstract

TH7 The rate of release of medicament from a controlled release tablet having a polymeric vinylpyrrolidonecarboxyvinyl hydrophilic core is improved by coating the medicament-containing core with a substantially water insoluble rupturable film which is water permeable and comprises a blend of hydrophobic polymer and hydrophilic polymer. [CA1097220A]
IE2231/76A 1975-10-10 1976-10-08 Controlled release tablet IE44540B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62131675A 1975-10-10 1975-10-10

Publications (2)

Publication Number Publication Date
IE44540L true IE44540L (en) 1977-04-10
IE44540B1 IE44540B1 (en) 1981-12-30

Family

ID=24489671

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2231/76A IE44540B1 (en) 1975-10-10 1976-10-08 Controlled release tablet

Country Status (16)

Country Link
JP (1) JPS5264420A (en)
AU (1) AU516051B2 (en)
BE (1) BE847095A (en)
CA (1) CA1097220A (en)
CH (1) CH616843A5 (en)
DE (1) DE2645547A1 (en)
DK (1) DK454876A (en)
FR (1) FR2326933A1 (en)
GB (1) GB1568837A (en)
HU (1) HU175540B (en)
IE (1) IE44540B1 (en)
NL (1) NL7611148A (en)
NO (1) NO763450L (en)
PH (1) PH14564A (en)
SE (1) SE435569B (en)
ZA (1) ZA765931B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU806037A1 (en) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Antianginal agent
JPS5626810A (en) * 1979-08-06 1981-03-16 Kurishiyuna Mitora Arun Antiacid delivering form controlled and treating method using said form
FR2494112B1 (en) * 1980-11-19 1986-01-10 Laruelle Claude
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
JPS6051106A (en) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd Long acting pharmaceutical preparation of amosulalol hydrochloride
HU190619B (en) 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3448522C2 (en) * 1983-11-11 1995-08-24 Egyt Gyogyszervegyeszeti Gyar Slow release tablets prepn. by wet granulation
FR2556965B1 (en) * 1983-12-21 1986-08-22 Rhone Poulenc Sante NEW GALENIC FORM OF CONTROLLED RELEASE KETOPROFEN
DE3420666A1 (en) 1984-06-02 1985-12-05 Mannesmann Rexroth GmbH, 8770 Lohr Level control device for vehicles with at least one hydraulic vibration damper
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
JPH0667828B2 (en) * 1985-10-09 1994-08-31 日研化学株式会社 Sustained valproate granule formulation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
JPH03145418A (en) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd Sustained release preparation of basic drug hydrochloride
IL119627A (en) 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet

Also Published As

Publication number Publication date
FR2326933A1 (en) 1977-05-06
JPS5264420A (en) 1977-05-27
FR2326933B1 (en) 1979-03-02
AU1844676A (en) 1978-04-13
SE7611241L (en) 1977-04-11
HU175540B (en) 1980-08-28
AU516051B2 (en) 1981-05-14
SE435569B (en) 1984-10-08
DE2645547A1 (en) 1977-04-14
ZA765931B (en) 1977-09-28
NO763450L (en) 1977-04-13
GB1568837A (en) 1980-06-04
IE44540B1 (en) 1981-12-30
NL7611148A (en) 1977-04-13
BE847095A (en) 1977-01-31
CA1097220A (en) 1981-03-10
PH14564A (en) 1981-09-24
CH616843A5 (en) 1980-04-30
DK454876A (en) 1977-04-11

Similar Documents

Publication Publication Date Title
IE44540L (en) Controlled release tablet
JPS51125468A (en) Method of preparing resins of high water absorbency
CA1035278A (en) Coatings of water-insoluble solid hydrophilic polymer
AU6193880A (en) Hydrophilic monomer treated microporous films
ES2001897A6 (en) Controlled release tablet.
AU501238B2 (en) Preparation of resinous polymer
GB1486288A (en) Hydrophobic substrates having grafted hydrophilic inclusions containing polar soluble substances
AU467158B2 (en) Polymer composition containing a graft copolymer
GB1466702A (en) Polymer encapsulated-activated carbon
ES422768A1 (en) Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
JPS536430A (en) Preparation of anticoagulant soft material for medical use
CA929430A (en) Photographic film of hydrophobic polymer coated with butadiene copolymer
CA1002238A (en) Hydrophobic radiation-sensitive polymer
JPS5223139A (en) Sticking agent
JPS53145877A (en) Manufacture of medical high polymer material
JPS57136513A (en) Material for controlling release of physiologically active substance
JPS545096A (en) Method of immobilizing enzyme or mold using betain polymer
JPS5223138A (en) Sticking agent
JPS5265422A (en) Photographic material
AU470465B2 (en) Hydrophilic polymer coating for underwater structures
JPS536429A (en) Preparation of anticoagulating medical material
CA1002237A (en) Hydrophobic radiation-sensitive polymer
JPS57130907A (en) Amlgam coating agent
CA999856A (en) Control of polymer degradation rate
CA1016694A (en) Preparation of resinous copolymers